Launched by the COVID-19 Therapeutics Accelerator, a Bill and Melinda Gates Foundation, Wellcome and MasterCard initiative.
The Coronavirus Immunotherapy Consortium (CoVIC) is a global, academic-industry, non-profit research collaboration that brings together scientists from around the world. We aim to understand which antibodies are most effective against the novel coronavirus SARS-CoV-2, and to streamline and accelerate the research pipeline for antibody-based therapeutics needed against SARS-CoV-2. Join us to prevent and treat this escalating threat to human health.
